VIRAL PRODUCTION AND TRANSDUCTION FOR GENE-EDITING USING MICROFLUIDICS

ABSTRACT

Viral production and transduction have seen a considerable increase in use for gene therapies and especially vaccines (e.g., COVID-19) due to their abilities to deliver a significant amount of genetic information and integrate it into the genome. However, challenges associated with viral production/transduction involve steps that are very time consuming, manually intensive, and laborious. In efforts to expedite this process, we have created a microfluidic methodology that will provide a “hands-off” workflow in the genome engineering pipeline. In this work, we developed a platform which can generate lentiviral particles on-demand containing the gene-editing machinery that will be able to modify target breast cancer cell lines. © 2021 MicroTAS 2021 - 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences. All rights reserved.